Cancer
Malignant Liver Neoplasm
CI-CAN-00003177Explore in graph →
Top-level908 active trials14 approved drugs17 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00003177Explore in graph →
Clinical trials
4,126 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (460)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03731923 | Abbreviated MRI for HCC Surveillance | unknown | N/A | 257 | Seoul National University HospitalOTHER | 1 | Aug 18, 2023 | clinicaltrials |
| NCT05996666 | Primary Liver Cancer Early Detection(PRIMe-liver) | unknown | — | 701 | The First Hospital of Jilin UniversityOTHER | 1 | Aug 18, 2023 | clinicaltrials |
| NCT04135690 | HAIC Plus Toripalimab vs. HAIC Plus Sorafenib for HCC With PVTT: a Non-comparative, Prospective, Randomized Trial | unknown | Phase 2 | 60 | Sun Yat-sen UniversityOTHER | 1 | Aug 15, 2023 | clinicaltrials |
| NCT05986383 | Multi-center Clinical Study on the Decision Tree of Precision Hepatectomy in China Precision Hepatectomy Decision Tree | unknown | — | 820 | Beijing Tsinghua Chang Gung HospitalOTHER | 0 | Aug 14, 2023 | clinicaltrials |
| NCT05987514 | Multimodal Ultrasound and Hepatocellular Response to Local Treatments | unknown | N/A | 50 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Aug 14, 2023 | clinicaltrials |
| NCT05981066 | A Clinical Study of mRNA Vaccine (ABOR2014/IPM511) in Patients With Advanced Hepatocellular Carcinoma | unknown | N/A | 48 | Peking Union Medical College HospitalOTHER | 1 | Aug 8, 2023 | clinicaltrials |
| NCT05970159 | Impact of Preoperative Serum Albumin Level on Postoperative Outcomes in Chinese HCC Patients Treated With Surgery(REAL) | unknown | — | 480 | Shanghai Zhongshan HospitalOTHER | 1 | Aug 3, 2023 | clinicaltrials |
| NCT04680598 | Comparison of HBV Reactivation Between Patients With High HBV-DNA and Low HBV-DNA Loads Undergoing ICI and Concurrent Antiviral Prophylaxis: a Prospective Observational Study | unknown | — | 800 | Sun Yat-sen UniversityOTHER | 1 | Aug 2, 2023 | clinicaltrials |
| NCT05971199 | Phase II Study of Fruquintinib Combined With Sintilimab and TACE for Inoperable Primary Hepatocellular Carcinoma | unknown | Phase 2 | 27 | Zhejiang Cancer HospitalOTHER | 1 | Aug 2, 2023 | clinicaltrials |
| NCT05967429 | Predictors of Sorafenib Response in HCC | unknown | — | 80 | Sohag UniversityOTHER | 0 | Aug 1, 2023 | clinicaltrials |
| NCT02557750 | Combined Modality Therapy in Hepatoblastoma: South Egypt Cancer Institute Experience | unknown | — | 35 | Assiut UniversityOTHER | 1 | Jul 24, 2023 | clinicaltrials |
| NCT05957640 | Yttrium-90 Carbon Microspheres in Patients With Unresectable Hepatocellular Carcinoma | unknown | Phase 1 | 40 | Zhongda HospitalOTHER | 1 | Jul 24, 2023 | clinicaltrials |
| NCT05576909 | Donafenib Combined With Hepatic Artery Chemoembolization for Perioperative Treatment of Liver Transplantation | unknown | Phase 2 | 20 | Beijing Tsinghua Chang Gung HospitalOTHER | 1 | Jul 13, 2023 | clinicaltrials |
| NCT05932719 | Multicentric Evaluation of COVID-19 Impact on Cancer Patients' Diagnostic and Management: Set-up of Indicators(COLLAT-COVID) | unknown | — | 4,000 | Hospices Civils de LyonOTHER | 1 | Jul 10, 2023 | clinicaltrials |
| NCT01082224 | Contrast-Enhanced CT and MRI in Diagnosing and Staging Liver Cancer Using UNOS Policy(ACRIN6690) | unknown | N/A | 440 | American College of Radiology Imaging NetworkNETWORK | 1 | Jul 7, 2023 | clinicaltrials |
| NCT04445532 | Hepatobiliary Tumors Tissue Samples Acquisition | unknown | — | 450 | Peking Union Medical College HospitalOTHER | 1 | Jul 7, 2023 | clinicaltrials |
| NCT05925413 | Cadonilimab Plus TACE in Patients With Intermediate-stage Unresectable Hepatocellular Carcinoma | unknown | Phase 2 | 41 | Eastern Hepatobiliary Surgery HospitalOTHER | 1 | Jun 29, 2023 | clinicaltrials |
| NCT04797884 | Electromagnetic Fields Versus Placebo For Child-Pugh A and B Patients With Advanced Hepatocellular Carcinoma(ARTEMIS) | unknown | Phase 2 / Phase 3 | 166 | THERABIONIC INC.OTHER | 1 | Jun 28, 2023 | clinicaltrials |
| NCT04512833 | CyberKnife Stereotactic Body Radiation Therapy for Small Hepatocellular Carcinoma Patients With Decompensated Cirrhosis | unknown | — | 60 | Beijing 302 HospitalOTHER | 1 | Jun 27, 2023 | clinicaltrials |
| NCT05897268 | Cryoablation Combined With Tislelizumab Plus Lenvatinib in 1L Treatment of Advanced HCC (CASTLE-10)(CASTLE-10) | unknown | Phase 2 | 25 | Fudan UniversityOTHER | 1 | Jun 27, 2023 | clinicaltrials |
| NCT05263219 | DEB-TACE+HAIC vs. HAIC for Large HCC | unknown | Phase 3 | 230 | Second Affiliated Hospital of Guangzhou Medical UniversityOTHER | 1 | Jun 22, 2023 | clinicaltrials |
| NCT05913141 | PDO/PDO-TIL/PDOTS for Drug Screen | unknown | — | 30 | Shanghai Zhongshan HospitalOTHER | 1 | Jun 22, 2023 | clinicaltrials |
| NCT05913583 | Correlation Between Pre-transplant ICI Exposure and Post-transplant Graft Rejection | unknown | — | 160 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Jun 22, 2023 | clinicaltrials |
| NCT05913661 | Pemigatinib Combined With PD-1 Inhibitor in Unresectable or Metastatic Intrahepatic Cholangiocarcinoma | unknown | Phase 2 | 30 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Jun 22, 2023 | clinicaltrials |
| NCT05908916 | Atezolizumab and Bevacizumab With Combined Radiotherapy for Advanced Hepatocellular Carcinoma | unknown | Phase 2 | 51 | Yonsei UniversityOTHER | 1 | Jun 18, 2023 | clinicaltrials |
| NCT05903456 | Icaritin Soft Capsule Combined With Lenvatinib and TACE for the Treatment of Hepatocellular Carcinoma | unknown | Phase 2 | 20 | Zhejiang Cancer HospitalOTHER | 0 | Jun 15, 2023 | clinicaltrials |
| NCT05889949 | Microvascular Invasion for Guiding Treatment of Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma | unknown | — | 200 | Sun Yat-sen UniversityOTHER | 1 | Jun 7, 2023 | clinicaltrials |
| NCT04769713 | Hepatic Hilar Nerve Block Versus Sham in Pain Control During Liver Ablation and TACE Procedures | unknown | Phase 4 | 80 | McGill University Health Centre/Research Institute of the McGill University Health CentreOTHER | 1 | Jun 2, 2023 | clinicaltrials |
| NCT05886075 | A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors | unknown | Early Phase 1 | 24 | Shanghai Yunying Medical TechnologyINDUSTRY | 1 | Jun 2, 2023 | clinicaltrials |
| NCT05886465 | HAIC Plus A+T for Patients With High-risk HCC: a Single-arm Phase 2 Trial | unknown | Phase 2 | 40 | Sun Yat-sen UniversityOTHER | 1 | Jun 2, 2023 | clinicaltrials |
| NCT04631731 | Risk Factors of Immune-ChEckpoint Inhibitors MEdiated Liver, Gastrointestinal, Endocrine and Skin Toxicity(ICEMELT) | unknown | Phase 1 / Phase 2 | 200 | Western Sydney Local Health DistrictOTHER | 1 | Jun 1, 2023 | clinicaltrials |
| NCT05703750 | Impact of Clinical Evident Portal Hypertension on HCC With TACE (CHANCE-CHESS 2301) | unknown | — | 228 | Zhongda HospitalOTHER | 1 | May 31, 2023 | clinicaltrials |
| NCT05704192 | CT-based HVPG Assessment for Predicting the Prognosis of HCC With TACE (CHANCE-CHESS 2302) | unknown | — | 373 | Zhongda HospitalOTHER | 1 | May 31, 2023 | clinicaltrials |
| NCT05883176 | TACE Combined With Bevacizumab in HCC (BCLC-B) Beyond Up-To-Seven Criteria(B-TACE) | unknown | Phase 2 | 35 | Sun Yat-sen UniversityOTHER | 1 | May 31, 2023 | clinicaltrials |
| NCT05879328 | The ImmunoXXL Study(ImmunoXXL) | unknown | — | 12 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | May 30, 2023 | clinicaltrials |
| NCT05875558 | M-TACE Treatment for Unresectable Hepatocellular Carcinoma | unknown | N/A | 40 | Shanghai Zhongshan HospitalOTHER | 1 | May 25, 2023 | clinicaltrials |
| NCT05876052 | HOPE to Reduce Tumour Recurrence After LT In Patients With HCC(POTERE) | unknown | N/A | 192 | University of BolognaOTHER | 1 | May 25, 2023 | clinicaltrials |
| NCT05872841 | H101 Combined With TACE for Primary Hepatocellular Carcinoma With Portal Vein Thrombosis | unknown | Phase 2 | 38 | Tianjin Medical University Cancer Institute and HospitalOTHER | 0 | May 24, 2023 | clinicaltrials |
| NCT05862181 | The Comparison Between HepaSphere Drug-eluting Bead Transarterial Chemoembolization Combined With Hepatic Arterial Infusion Chemotherapy in Advanced Hepatocellular Carcinoma | unknown | — | 200 | Peking University Cancer Hospital & InstituteOTHER | 1 | May 22, 2023 | clinicaltrials |
| NCT05866172 | HAIC Combined Withzoledronic Acid for the Prevention of Bone Metastases in Advanced HCC | unknown | Phase 3 | 264 | Sun Yat-sen UniversityOTHER | 1 | May 19, 2023 | clinicaltrials |
| NCT04967495 | TACE Plus Multikinase Inhibitor and I-125 Seeds Brachytherapy for HCC With Branch PVTT | unknown | N/A | 171 | Second Affiliated Hospital of Guangzhou Medical UniversityOTHER | 1 | May 18, 2023 | clinicaltrials |
| NCT05859945 | Navigating the Clinical Trial Process for Hepatocellular Carcinoma | unknown | — | 500 | Power Life Sciences Inc.INDUSTRY | 0 | May 16, 2023 | clinicaltrials |
| NCT05860374 | A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Solid Tumors | unknown | Early Phase 1 | 20 | Shanghai Yunying Medical TechnologyINDUSTRY | 1 | May 16, 2023 | clinicaltrials |
| NCT04111029 | Liquid Biopsy in Hepatocellular Carcinoma(HCCGenePanel) | unknown | — | 30 | Post Graduate Institute of Medical Education and Research, ChandigarhOTHER | 1 | May 3, 2023 | clinicaltrials |
| NCT05837065 | Prognostic Models for HCC Based on Tumor Micronecrosis | unknown | — | 765 | Zhejiang UniversityOTHER | 1 | May 1, 2023 | clinicaltrials |
| NCT05134532 | Regorafenib After Progression on Atezolizumab Plus Bevacizumab in Advanced HCC(HCC) | unknown | Phase 2 | 40 | CHA UniversityOTHER | 1 | Apr 26, 2023 | clinicaltrials |
| NCT04454905 | Camrelizumab in Combination With Apatinib in Advanced ICC: A Single-arm Phase II Study | unknown | Phase 2 | 50 | Sun Yat-sen UniversityOTHER | 1 | Apr 19, 2023 | clinicaltrials |
| NCT04652440 | Ablation Combined With PD-1 in HCC: Phase II Study | unknown | Phase 1 / Phase 2 | 30 | Sun Yat-sen UniversityOTHER | 1 | Apr 19, 2023 | clinicaltrials |
| NCT05816837 | Displacement Distance and Stabilization Time for Liver Fiducial Marker | unknown | — | 30 | Peking University Third HospitalOTHER | 1 | Apr 18, 2023 | clinicaltrials |
Data updated 23 days agoSource updated Aug 18, 2023source: clinicaltrials